{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:46:48Z","timestamp":1794008808518,"version":"4.8.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Health Research Grant (MRG), Malaysia","award":["NMRR-21-31-58059"],"award-info":[{"award-number":["NMRR-21-31-58059"]}]},{"name":"Ministry of Health Research Grant (MRG), Malaysia","award":["NMRR-21-31-58059"],"award-info":[{"award-number":["NMRR-21-31-58059"]}]},{"name":"Ministry of Health Research Grant (MRG), Malaysia","award":["NMRR-21-31-58059"],"award-info":[{"award-number":["NMRR-21-31-58059"]}]},{"name":"Ministry of Health Research Grant (MRG), Malaysia","award":["NMRR-21-31-58059"],"award-info":[{"award-number":["NMRR-21-31-58059"]}]},{"name":"Ministry of Health Research Grant (MRG), Malaysia","award":["NMRR-21-31-58059"],"award-info":[{"award-number":["NMRR-21-31-58059"]}]},{"name":"Ministry of Health Research Grant (MRG), Malaysia","award":["NMRR-21-31-58059"],"award-info":[{"award-number":["NMRR-21-31-58059"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-38856-2","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T14:51:58Z","timestamp":1770389518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacogenomic profiling of ABCB1 and CES1 in atrial fibrillation patients on dabigatran from a multiethnic Malaysian cohort"],"prefix":"10.1038","volume":"16","author":[{"given":"Shirley Siang Ning","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund Ui-Hang","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Adrian","family":"Jinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa Siaw Han","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra Sheau Mei","family":"Chee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Anchah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiful Shakirin","family":"Rosli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice Bangie Desmond","family":"Sateng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Gerunsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee Len","family":"Tiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan Yean Yip","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"38856_CR1","doi-asserted-by":"crossref","unstructured":"Linz, D. et al. Atrial fibrillation: epidemiology, screening and digital health. Lancet Reg. Health \u2013 Europe 37 (2024).","DOI":"10.1016\/j.lanepe.2023.100786"},{"issue":"3","key":"38856_CR2","first-page":"1","volume":"19","author":"Y Guo","year":"2012","unstructured":"Guo, Y., Lip, G. Y. & Apostolakis, S. The unmet need of stroke prevention in atrial fibrillation in the Far East and South East Asia. Malays J. Med. Sci. 19 (3), 1\u20137 (2012).","journal-title":"Malays J. Med. Sci."},{"issue":"1","key":"38856_CR3","doi-asserted-by":"publisher","first-page":"e003122","DOI":"10.1136\/openhrt-2024-003122","volume":"12","author":"Z Manlin","year":"2025","unstructured":"Manlin, Z. & Gregory, Y. H. L. Stroke and bleeding risks in Asian and non-Asian patients with atrial fibrillation: further insights into the \u00e2East Asian Paradox\u00e2. Open. Heart. 12 (1), e003122 (2025).","journal-title":"Open. Heart"},{"issue":"7","key":"38856_CR4","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1111\/jth.14457","volume":"17","author":"S Testa","year":"2019","unstructured":"Testa, S. et al. Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants. J. Thromb. Haemost. 17 (7), 1064\u20131072 (2019).","journal-title":"J. Thromb. Haemost"},{"issue":"10","key":"38856_CR5","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/europace\/euab065","volume":"23","author":"J Steffel","year":"2021","unstructured":"Steffel, J. et al. 2021 European heart rhythm association practical guide on the use of Non-Vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. EP Europace. 23 (10), 1612\u20131676 (2021).","journal-title":"EP Europace"},{"key":"38856_CR6","doi-asserted-by":"crossref","unstructured":"Kanuri, S. H. & Kreutz, R. P. Pharmacogenomics of novel direct oral anticoagulants: newly identified genes and genetic variants. J. Pers. Med. ;9(1). 7 (2019).","DOI":"10.3390\/jpm9010007"},{"issue":"16","key":"38856_CR7","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","volume":"39","author":"J Steffel","year":"2018","unstructured":"Steffel, J. et al. The 2018 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur. Heart J. 39 (16), 1330\u20131393 (2018).","journal-title":"Eur. Heart J."},{"issue":"13","key":"38856_CR8","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1161\/CIRCULATIONAHA.112.001233","volume":"127","author":"G Par\u00e9","year":"2013","unstructured":"Par\u00e9, G. et al. Genetic determinants of Dabigatran plasma levels and their relation to bleeding. Circulation 127 (13), 1404\u20131412 (2013).","journal-title":"Circulation"},{"key":"38856_CR9","doi-asserted-by":"publisher","first-page":"873031","DOI":"10.3389\/fgene.2022.873031","volume":"13","author":"Q Xie","year":"2022","unstructured":"Xie, Q. et al. SLC4A4, FRAS1, and SULT1A1 genetic variations associated with Dabigatran metabolism in a healthy Chinese population. Front. Genet. 13, 873031 (2022).","journal-title":"Front. Genet."},{"issue":"12","key":"38856_CR10","doi-asserted-by":"publisher","first-page":"e1104","DOI":"10.1002\/ctm2.1104","volume":"12","author":"Q Xiang","year":"2022","unstructured":"Xiang, Q. et al. Genetic variations in relation to bleeding and pharmacodynamics of Dabigatran in Chinese patients with nonvalvular atrial fibrillation: A nationwide multicentre prospective cohort study. Clin. Translational Med. 12 (12), e1104 (2022).","journal-title":"Clin. Translational Med."},{"key":"38856_CR11","first-page":"127","volume":"11","author":"DA Sychev","year":"2018","unstructured":"Sychev, D. A. et al. The impact of ABCB1 (rs1045642 and rs4148738) and CES1 (rs2244613) gene polymorphisms on Dabigatran equilibrium peak concentration in patients after total knee arthroplasty. Pharmgenomics Pers. Med. 11, 127\u2013137 (2018).","journal-title":"Pharmgenomics Pers. Med."},{"key":"38856_CR12","doi-asserted-by":"crossref","unstructured":"Kang, S. H. et al. Differential Event Rates and Independent Predictors of Long-Term Major Cardiovascular Events and Death in 5795 Patients With Unprotected Left Main Coronary Artery Disease Treated With Stents, Bypass Surgery, or Medication. Circulation: Cardiovascular Interventions. ;10(7):e004988. (2017).","DOI":"10.1161\/CIRCINTERVENTIONS.116.004988"},{"issue":"23","key":"38856_CR13","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","volume":"123","author":"R Mehran","year":"2011","unstructured":"Mehran, R. et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation 123 (23), 2736\u20132747 (2011).","journal-title":"Circulation"},{"issue":"17","key":"38856_CR14","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34 (17), i884\u2013i90 (2018).","journal-title":"Bioinformatics"},{"issue":"14","key":"38856_CR15","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics 25 (14), 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"38856_CR16","doi-asserted-by":"crossref","unstructured":"Van der Auwera, G. A. et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics. ;43(1110):11.0.1-.0.33. (2013).","DOI":"10.1002\/0471250953.bi1110s43"},{"key":"38856_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).","journal-title":"Gigascience"},{"issue":"10","key":"38856_CR18","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1038\/nprot.2015.105","volume":"10","author":"H Yang","year":"2015","unstructured":"Yang, H. & Wang, K. Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR. Nat. Protoc. 10 (10), 1556\u20131566 (2015).","journal-title":"Nat. Protoc."},{"issue":"5","key":"38856_CR19","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1111\/bcp.14646","volume":"87","author":"Q Ji","year":"2021","unstructured":"Ji, Q. et al. The impact of ABCB1 and CES1 polymorphisms on Dabigatran pharmacokinetics and pharmacodynamics in patients with atrial fibrillation. Br. J. Clin. Pharmacol. 87 (5), 2247\u20132255 (2021).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"38856_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s12872-022-02910-4","volume":"22","author":"Z Zhu","year":"2022","unstructured":"Zhu, Z. et al. The impact of ABCB1 and CES1 polymorphisms on the safety of Dabigatran in patients with non-valvular atrial fibrillation. BMC Cardiovasc. Disord. 22 (1), 481 (2022).","journal-title":"BMC Cardiovasc. Disord."},{"key":"38856_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.thromres.2016.05.025","volume":"144","author":"C Dimatteo","year":"2016","unstructured":"Dimatteo, C. et al. Pharmacogenetics of Dabigatran etexilate interindividual variability. Thromb. Res. 144, 1\u20135 (2016).","journal-title":"Thromb. Res."},{"issue":"5","key":"38856_CR22","first-page":"333","volume":"45","author":"T Veleta","year":"2024","unstructured":"Veleta, T. et al. Pharmacogenetics of Dabigatran and Apixaban in association with Gastrointestinal bleeding. Neuro Endocrinol. Lett. 45 (5), 333\u2013340 (2024).","journal-title":"Neuro Endocrinol. Lett."},{"issue":"3","key":"38856_CR23","first-page":"499","volume":"15","author":"A Abdrakhmanov","year":"2024","unstructured":"Abdrakhmanov, A. et al. Genetic variants of ABCB1 and CES1 genes on Dabigatran metabolism in the Kazakh population. Casp. J. Intern. Med. 15 (3), 499\u2013508 (2024).","journal-title":"Casp. J. Intern. Med."},{"issue":"9","key":"38856_CR24","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1001\/jamadermatol.2020.1867","volume":"156","author":"R N\u00fa\u00f1ez-Torres","year":"2020","unstructured":"N\u00fa\u00f1ez-Torres, R. et al. Association between ABCB1 genetic variants and persistent Chemotherapy-Induced alopecia in women with breast cancer. JAMA Dermatol. 156 (9), 987\u2013991 (2020).","journal-title":"JAMA Dermatol."},{"issue":"3","key":"38856_CR25","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/npp.2011.257","volume":"37","author":"A Menke","year":"2012","unstructured":"Menke, A. et al. Genome-wide association study of antidepressant treatment-emergent suicidal ideation. Neuropsychopharmacology 37 (3), 797\u2013807 (2012).","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"38856_CR26","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41397-018-0016-6","volume":"18","author":"JE Kim","year":"2018","unstructured":"Kim, J. E. et al. Associations between genetic polymorphisms of membrane transporter genes and prognosis after chemotherapy: meta-analysis and finding from Seoul breast cancer study (SEBCS). Pharmacogenomics J. 18 (5), 633\u2013645 (2018).","journal-title":"Pharmacogenomics J."},{"issue":"1","key":"38856_CR27","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.4102\/sajhivmed.v22i1.1206","volume":"22","author":"EH Decloedt","year":"2021","unstructured":"Decloedt, E. H. et al. Pharmacogenetics of Tenofovir and emtricitabine penetration into cerebrospinal fluid. South. Afr. J. HIV Med. 22 (1), 1206 (2021).","journal-title":"South. Afr. J. HIV Med."},{"issue":"2","key":"38856_CR28","first-page":"185","volume":"2","author":"P Peethambaram","year":"2011","unstructured":"Peethambaram, P. et al. Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome. Int. J. Mol. Epidemiol. Genet. 2 (2), 185\u2013195 (2011).","journal-title":"Int. J. Mol. Epidemiol. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38856-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38856-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38856-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:09:00Z","timestamp":1771978140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38856-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["38856"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-38856-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7539"}}